185 related articles for article (PubMed ID: 28636686)
21. Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid.
Ishiura N; Fujimoto M; Watanabe R; Nakashima H; Kuwano Y; Yazawa N; Echigo T; Okochi H; Tamaki K
J Dermatol Sci; 2008 Feb; 49(2):153-61. PubMed ID: 17920818
[TBL] [Abstract][Full Text] [Related]
22. Possible enhancement of BP180 autoantibody production by herpes zoster.
Kamiya K; Aoyama Y; Suzuki T; Niwa H; Horio A; Nishio E; Tokura Y
J Dermatol; 2016 Feb; 43(2):197-9. PubMed ID: 26212492
[TBL] [Abstract][Full Text] [Related]
23. Bullous pemphigoid of infancy - report and review of infantile and pediatric bullous pemphigoid.
Ferreira BR; Vaz AS; Ramos L; Reis JP; Gonçalo M
Dermatol Online J; 2017 Feb; 23(2):. PubMed ID: 28329498
[TBL] [Abstract][Full Text] [Related]
24. Erythema Multiforme-Like Bullous Pemphigoid.
Imbernón-Moya A; Aguilar A; Burgos F; Gallego MÁ
Actas Dermosifiliogr; 2016 Oct; 107(8):689-91. PubMed ID: 27048923
[No Abstract] [Full Text] [Related]
25. Biological and Clinical Response to Omalizumab in a Patient with Bullous Pemphigoid.
Menzinger S; Kaya G; Schmidt E; Fontao L; Laffitte E
Acta Derm Venereol; 2018 Feb; 98(2):284-286. PubMed ID: 29136264
[No Abstract] [Full Text] [Related]
26. Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid.
Feng S; Wu Q; Jin P; Lin L; Zhou W; Sang H; Shao C
Int J Dermatol; 2008 Mar; 47(3):225-8. PubMed ID: 18289320
[TBL] [Abstract][Full Text] [Related]
27. Bullous pemphigoid in infancy with spontaneous remission.
Nomura H; Funakoshi T; Baba A; Tanikawa A; Hayakawa K; Amagai M
Eur J Dermatol; 2017 Feb; 27(1):95-96. PubMed ID: 27762214
[No Abstract] [Full Text] [Related]
28. Levels of anti-BP180 NC16A IgE do not correlate with severity of disease in the early stages of bullous pemphigoid.
Bing L; Xiping Z; Li L; Jun P; Yi-Xia W; Min Y; Qing L; Qiu-Ning S; Hong-Zhong J; Ya-Gang Z
Arch Dermatol Res; 2015 Nov; 307(9):849-54. PubMed ID: 26404084
[TBL] [Abstract][Full Text] [Related]
29. Bullous pemphigoid positive for anti-BP180 and anti-laminin 5 antibodies in a patient with graft-vs-host disease.
Izumi R; Fujimoto M; Yazawa N; Nakashima H; Asashima N; Watanabe R; Kuwano Y; Kurokawa M; Hashimoto T; Tamaki K
J Am Acad Dermatol; 2007 May; 56(5 Suppl):S94-7. PubMed ID: 17434049
[TBL] [Abstract][Full Text] [Related]
30. Peristomal bullous pemphigoid.
Marzano AV; Vezzoli P; Colombo A; Serini SM; Crosti C; Berti E
J Dermatol; 2010 Sep; 37(9):840-2. PubMed ID: 20883375
[No Abstract] [Full Text] [Related]
31. Vesicular pemphigoid with circulating autoantibodies against 230-kDa and 180-kDa proteins, and additional autoantibodies against 97-kDa and 45-kDa proteins.
Lai FJ; Sheu HM; Lee JY; Cheng CL; Chen W
Int J Dermatol; 2007 Feb; 46(2):206-9. PubMed ID: 17269979
[TBL] [Abstract][Full Text] [Related]
32. A new clinical variant of acquired reactive perforating dermatosis-like bullous pemphigoid.
Schauer F; Kern JS; Virtic O; Technau-Hafsi K; Meiss F; Thoma K; Athanasiou I; Sitaru C; Di Zenzo G; Izumi K; Nishie W; Shimizu H; Bruckner-Tuderman L; Kiritsi D
Br J Dermatol; 2019 Jan; 180(1):231-232. PubMed ID: 30188568
[No Abstract] [Full Text] [Related]
33. Clinical features and practical diagnosis of bullous pemphigoid.
Schmidt E; della Torre R; Borradori L
Immunol Allergy Clin North Am; 2012 May; 32(2):217-32, v. PubMed ID: 22560135
[TBL] [Abstract][Full Text] [Related]
34. Detection of anti-BP180NC16a and anti-BP230 autoantibodies in blister fluid of patients with bullous pemphigoid: the first survey in Greece.
Patsatsi A; Vyzantiadis TA; Devliotou-Panagiotidou D; Chrysomallis F; Sotiriadis D
Clin Exp Dermatol; 2008 Mar; 33(2):183-5. PubMed ID: 18093242
[TBL] [Abstract][Full Text] [Related]
35. Autoantibodies to basement membrane proteins BP180 and BP230 are commonly detected in normal subjects by immunoblotting.
Desai N; Allen J; Ali I; Venning V; Wojnarowska F
Australas J Dermatol; 2008 Aug; 49(3):137-41. PubMed ID: 18638220
[TBL] [Abstract][Full Text] [Related]
36. Bullous pemphigoid induced by pembrolizumab in a patient with advanced melanoma expressing collagen XVII.
Wada N; Uchi H; Furue M
J Dermatol; 2017 Oct; 44(10):e240-e241. PubMed ID: 28677843
[No Abstract] [Full Text] [Related]
37. Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid.
Yoshida M; Hamada T; Amagai M; Hashimoto K; Uehara R; Yamaguchi K; Imamura K; Okamoto E; Yasumoto S; Hashimoto T
J Dermatol Sci; 2006 Jan; 41(1):21-30. PubMed ID: 16364599
[TBL] [Abstract][Full Text] [Related]
38. Autoantibody serum levels and intensity of pruritus in bullous pemphigoid.
Bardazzi F; Barisani A; Magnano M; Tengattini V; La Placa M; Patrizi A; Balestri R
Eur J Dermatol; 2016 Aug; 26(4):390-1. PubMed ID: 27210833
[No Abstract] [Full Text] [Related]
39. Case of papuloerythroderma of Ofuji-like eruption during the course of bullous pemphigoid.
Hayakawa-Asai R; Nobeyama Y; Maki T; Asahina A; Nakagawa H
J Dermatol; 2018 Mar; 45(3):e63-e64. PubMed ID: 29205461
[No Abstract] [Full Text] [Related]
40. Correlation of autoantibodies against BP180/BP230 in response to topical corticosteroids in patients with bullous pemphigoid.
Schneiderbauer R; Martinache S; Engstner M; Enk AH; Hadaschik EN
Dermatol Ther; 2016 Nov; 29(6):419-423. PubMed ID: 27550573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
